China Medical & HealthCare Group Limited provided earnings guidance for the first quarter ended March 31, 2020. The board of directors of the Company updated the Shareholders and potential investors that based on its preliminary review on the relevant unaudited consolidated management accounts of the Group for the three months ended 31 March 2020 and information currently available, the Group is expected to record a decrease of approximately 34% in the revenue for the three months ended 31 March 2020 as compared to the corresponding period in 2019. The loss attributable to shareholders of the Company for the three months ended 31 March 2020 (subject to any further impairment or other adjustments) is expected to be in a range of approximately HKD 69 million to HKD 84 million as compared with a profit for the same period in 2019. Loss attributable to the shareholders of the Company as compared with a profit for the same period in 2019 mainly due to (i) the decrease in revenue from the operations of the Healthcare Division and the Eldercare Division as affected by the emergency public health measures in the PRC; (ii) no interest income from the money lending business; and (iii) a loss in fair value change of investments held for trading compared with a gain recorded in the corresponding period in 2019.